Memorial Sloan-Kettering Cancer Center (New York, USA) Emily Cheng 研究室では下記のとおりポスドクを募集しております。応募される方は、chengpostdocapps@gmail.comまでCV及び推薦者3名の連絡リストをお送りください。なお、日本語でのご質問等ございましたら、ポスドクの山内茜 (yamaucha@mskcc.org)、小山敏尚 (oyamat@mskcc.org) までお気軽にお問合せ下さい。
-------
Post-doctoral positions are available for highly motivated candidates with a strong background in biochemistry, molecular biology, cell biology, and/or mouse genetics to join a research group studying the BCL-2 family, the fundamental mechanisms of cell death, and the impact of cell death regulators on tumorigenesis and cancer therapy (Science 330: 1390-1393; Molecular Cell 36: 487-499; Nature Cell Biology 8:1348-1358; Science Signaling 2: ra48; Science 301:513-517). Projects will include characterization of cell death mechanisms using biochemistry, proteomics or next-generation high-resolution imaging studies, delineation of cell death pathways in vivo using mouse models, high throughput functional genomics and chemical screens to identify modulators for cancer-specific cell death mechanisms, and development of cell death mechanism-based targeted therapies. Applicants should hold a PhD and/or MD degree and have strong laboratory and analytical skills. Special consideration !
will be given to candidates who have prior experience in biochemistry, mitochondrial physiology, TIRF microscopy, stochastic optical reconstruction microscopy (STORM) or Photo-activated localization microscopy (PALM).
Full applications include curriculum vitae, a description of past research experience and accomplishments, and a list of three references. Please submit the application material through chengpostdocapps@gmail.com to: Emily Cheng, M.D., Ph.D., Associate Member, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA.